Idaho Diabetes-Endocrine Assoc is categorized under Internal Medicine Practitioners in Boise, ID and active since 1993.
Idaho Diabetes-Endocrine Assoc was established in 1993, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number by the NAICS.
If you are seeking more information, feel free to contact Kim Gillin at the company’s single location by writing to 9196 W Emerald Street
Suite 160, Boise, Idaho ID 83704 or by phoning (208) 389-2213. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Idaho Diabetes-Endocrine Assoc |
Contact Person: | Kim Gillin |
Address: | 9196 W Emerald Street Suite 160, Boise, Idaho 83704 |
Phone Number: | (208) 389-2213 |
Website Address: | idahodiabetes.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1993 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Practitioners |
Share This Business: |
Idaho Diabetes-Endocrine Assoc was started in 1993 to provide professional Internal Medicine Practitioners under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Kim Gillin for inquiries that concern Idaho Diabetes-Endocrine Assoc by calling the company number (208) 389-2213, as your correspondence is most welcome.
Additionally, the physical location of the single location of Idaho Diabetes-Endocrine Assoc can be found at the coordinates 43.61097,-116.29524 as well as the street address 9196 W Emerald Street
Suite 160 in Boise, Idaho 83704.
For its online presence, you may visit Idaho Diabetes-Endocrine Assoc’s website at idahodiabetes.com and engage with its social media outlets through on Twitter and on Facebook.